HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of ABO or related antigenic carbohydrates on viral envelopes leads to neutralization in the presence of serum containing specific natural antibodies and complement.

Abstract
No definitive biologic function has been associated with the human ABO histo-blood group polymorphism, or any other terminal carbohydrate differences within or between closely related species. We have experimentally addressed the question of whether viral particles can become glycosylated as determined by the glycosylation (eg, ABO) status of the producer cell and as a result be affected by human serum containing specific natural antibodies (NAbs). Measles virus was produced in cells transfected with cDNA encoding, either human A-transferase, B-transferase, an inactive "O-transferase," or a pig alpha1-3galactosyltransferase (alpha1-3GT) synthesizing the Galalpha1-3Gal structure. The viruses were shown to carry the same ABO structures as the cells; that is, A but not B if produced in A-type cells, and B but not A if produced in B-type cells. Only O was detected on the virus produced from O-type cells, whereas reduced amounts of O appeared on the A- and B-type viral particles. In addition, the Galalpha1-3Gal structure was transferred onto measles only when grown in human cells expressing this structure. When subjected to human preimmune sera, the A-type, the B-type, and the Galalpha1-3Gal viral particles were partially neutralized in a complement-dependent manner. However, the O-type or the Galalpha1-3Gal-negative viral particles were not neutralized. The neutralization appeared to be mediated by specific NAb, as judged by specific inhibition using synthetic A and Galalpha1-3Gal oligosaccharides. Such viral glycosylation may thus partly explain why the ABO antigens and other similar intraspecies as well as interspecies polymorphic carbohydrates have evolved and been maintained over long evolutionary periods.
AuthorsAndrew F Preece, Karen M Strahan, James Devitt, Fumi-ichiro Yamamoto, Kenth Gustafsson
JournalBlood (Blood) Vol. 99 Issue 7 Pg. 2477-82 (Apr 01 2002) ISSN: 0006-4971 [Print] United States
PMID11895782 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ABO Blood-Group System
  • Antibodies
  • Antigens, Viral
  • Carbohydrates
  • Disaccharides
  • Epitopes
  • Viral Envelope Proteins
  • galactosyl-(1-3)galactose
  • Complement System Proteins
  • Coenzyme A-Transferases
Topics
  • ABO Blood-Group System (immunology)
  • Antibodies (blood)
  • Antigens, Viral (immunology)
  • Carbohydrates (immunology)
  • Coenzyme A-Transferases (blood)
  • Complement System Proteins (physiology)
  • Disaccharides (immunology)
  • Epitopes (immunology)
  • HeLa Cells
  • Humans
  • Neutralization Tests
  • Transfection
  • Viral Envelope Proteins (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: